Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Treatment begins in phase III PI-88 study

Sep. 29, 2011

Sunesis begins phase I trial of MLN-2480

Sep. 29, 2011

Riemser Arzneimittel receives German license for CINV combination therapy

Sep. 29, 2011

CytRx to increase enrollment in INNO-206 clinical trial

Sep. 28, 2011

Photocure and Ipsen to commercialize Hexvix

Sep. 28, 2011

CHMP issues opinion on new indication for Avastin

Sep. 28, 2011

CHMP recommends approval of Alimta for new indication

Sep. 27, 2011

Ono Pharmaceutical obtains approval in Japan for intravenous Proemend

Sep. 27, 2011

Piramal Life Sciences patents novel TGF-beta inhibitors for cancer

Sep. 27, 2011

Additional FDA orphan drug designation for resminostat

Sep. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...